A Marked Response to Immunosuppressive Intervention for Abruptly Occurring Cardiac Complications in a Case of Juvenile Systemic Sclerosis Overlapped with Dermatomyositis.
Tsunehisa NagamoriYoichiro YoshidaHironori TakahashiHideharu OkaAya KajihamaKoichi NakauMasaya SugimotoMasako Minami-HoriHiroshi AzumaPublished in: Case reports in pediatrics (2017)
Juvenile-onset systemic sclerosis (jSSc) is a rare condition, having unique characteristic features compared to adult-onset SSc. Although cardiac involvement (CI) is known as a leading cause of mortality overall in SSc, the importance of CI in jSSc has not been emphasized. Here we present a 13-year-old female with jSSc overlapped with dermatomyositis (DM) complicated CI. She developed skin thickness and induration, Raynaud's phenomenon, digital pitting scars in fingertips, and skeletal myositis. Oral prednisolone and pulse methotrexate treatment led to the improvement of skin findings; however two weeks after the initiation she suddenly presented with muscle pain and dyspnea within a few days. Cardiac investigations then showed pericardiac effusion and diastolic dysfunction due to significant biventricular hypertrophy causing heart failure. As pericardiac effusion and exacerbation of skeletal myositis were evident, steroid pulse therapy was initiated. Unexpectedly, not only the myositis but also the CI including diastolic dysfunction was improved. She thereafter followed a favorable clinical course without reactivation of the CI or cardiac fibrosis. As a conclusion, close attention to CI must be paid in jSSc patients, especially when skeletal muscle involvement is evident and immunosuppressive therapy may be effective for CI in jSSc in cases where it occurs abruptly.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- left ventricular
- skeletal muscle
- heart failure
- blood pressure
- ejection fraction
- rheumatoid arthritis
- idiopathic pulmonary fibrosis
- cardiac resynchronization therapy
- newly diagnosed
- oxidative stress
- randomized controlled trial
- chronic pain
- chronic obstructive pulmonary disease
- risk factors
- insulin resistance
- neuropathic pain
- type diabetes
- stem cells
- high dose
- low dose
- cardiovascular events
- prognostic factors
- atrial fibrillation
- wound healing
- acute respiratory distress syndrome
- systemic lupus erythematosus
- acute heart failure
- extracorporeal membrane oxygenation
- liver fibrosis
- replacement therapy